T. Rowe Price Group, Inc. · TROW · FY2024 Q4 · Calendar Q1 2025

T. Rowe Price highlights ETF and retirement growth amid outflows

The supplied analysis supports a cautiously constructive operating thesis: ETF, target-date, insurance, and alternatives initiatives are gaining traction, but sustained improvement depends on converting those channels into durable flows while managing fee and cost pressure.

Reported Before market openNASDAQFinancial Services $22.23B market cap
80quality score

Earnings scorecard

Reported versus consensus
Reported EPS — Consensus $2.20
EPS surprise — Reported versus consensus
Reported revenue — Consensus $1.88B
Revenue surprise — Reported versus consensus

Market reaction

prior-close to event-session close
Stock move -4.2% Event window
SPY move +0.4% Same window
Abnormal move -4.6% Stock minus SPY
Volume 2.0× Versus trailing sessions
Subsequent drift -10.7% Up to 20 sessions
TROWSPY benchmark

Ask FN2 about TROW FY2024 Q4

Transcript, numbers and history already loaded

Free account. Your question opens in FN2 with this report's transcript and numbers attached.

Transcript intelligence

What changed

Compared with the prior-quarter analysis, the focus shifted from a large expected variable-annuity redemption and product rollout to evidence of improved full-year outflows, stronger ETF and target-date inflows, and broader insurance and alternatives capabilities. Fee compression, regulation, and cost discipline remain central constraints.

Guidance delta

Management guidance sentiment was maintained; no new numerical guidance was supplied in the analysis.

Key takeaways

  • Management highlighted ETF expansion, with the franchise at nearly $8 billion of AUM and $4.7 billion of net inflows.
  • The target-date franchise generated $16.3 billion of inflows, while full-year net outflows were $43.2 billion.
  • Insurance and alternatives capabilities expanded through the Aspida-Ares partnership and new fund launches.
  • Cost discipline, fee compression, and regulatory limits remain important counterweights to the growth initiatives.

Management priorities

  • Expand the ETF lineup, including premium-income and hedged-equity products.
  • Develop personalized retirement, managed-lifetime-income, and target-date offerings.
  • Build insurance, private-credit, and public-private investment capabilities.
  • Continue AI/ML investment and pursue structural cost savings of 2–3% annually.

Follow TROW with an agent that reads every filing, transcript, and price print. Free to start.

Try FN2 free

Earnings History

Estimate Beat Miss Match
TROW EPS earnings history estimate and actual scatter chart 9 reported fiscal quarters and 3 future estimate-only quarters. Q4 '23 estimate $1.60 Q4 '23 actual $1.72, beat Q1 '24 estimate $2.04 Q1 '24 actual $2.38, beat Q2 '24 estimate $2.27 Q2 '24 actual $2.26, match Q3 '24 estimate $2.33 Q3 '24 actual $2.57, beat Q2 '25 estimate $2.15 Q2 '25 actual $2.24, beat Q3 '25 estimate $2.54 Q3 '25 actual $2.81, beat Q4 '25 estimate $2.46 Q4 '25 actual $2.44, miss Q1 '26 estimate $2.33 Q1 '26 actual $2.52, beat Q2 '26 estimate $2.51 Q2 '26 actual $2.57, beat Q3 '26 estimate $2.63 Q4 '26 estimate $2.49 Q1 '27 estimate $2.65
Show less

Analyst Consensus ?

ConsensusHold37 ratings
Bullish821.6%
Neutral2362.2%
Bearish616.2%

Analyst 52W Price Targets

$104.2Current
$87Low
$118.82Average
$215High

Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 25, 2026. Not an FN2 forecast.

Firm-level rating actions

FMP grade actions identify the grading firm, not a named analyst.

FirmRatingPrior ratingActionDate
Morgan Stanley Equal Weight Equal WeightMaintainOct 23, 2026
Barclays Underweight UnderweightMaintainOct 14, 2026
JP Morgan Underweight UnderweightMaintainOct 13, 2026
BMO Capital Market Perform Market PerformMaintainOct 13, 2026
TD Cowen Hold HoldMaintainOct 12, 2026
Show 32 more rating actions

Named analyst price targets

Upside is calculated against the persisted current price $104.2. FMP does not supply a rating on these named-analyst rows.

FirmAnalyst52W targetPrice when postedUpsideDate
Morgan StanleyAnalyst unavailable$112$102.46 +7.5%Oct 23, 2026
Evercore ISIGlenn Schorr$109$104.94 +4.6%Oct 9, 2026
UBSAnalyst unavailable$107$103.16 +2.7%Oct 7, 2026
Morgan StanleyAnalyst unavailable$110$104.27 +5.6%Sep 25, 2026
UBSAnalyst unavailable$110$110.97 +5.6%Aug 31, 2026
See 43 more

Track every rating change on TROW the moment it posts. Free to start.

Start free

Company context

Snapshot as of publication

T. Rowe Price Group, Inc. operates as a publicly traded entity specializing in investment management. The firm extends its financial expertise to a diverse range of clients, including individual investors, institutional organizations, retirement benefit plans, and financial intermediaries. It is responsible for the establishment and ongoing management of both equity and fixed income mutual funds. The company's investment activities encompass public stock and bond markets worldwide. Employing a bottom-up methodology, the firm integrates both fundamental and quantitative analysis, leveraging insights from both internal research capabilities and external sources for its investment decisions. A core tenet of its investment philosophy is socially responsible investing, with a significant emphasis on environmental, social, and governance (ESG) factors. Furthermore, T.…

Historical context

All TROW earnings

Financial Services peers this season

Latest reports in the same sector

Latest beats and misses

Who reports next

Get the TROW recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.

Sources

  1. Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
  2. FN2 earnings calendar · 2025-01-22T00:04:22.296664+00:00
  3. Polygon adjusted daily market bars · 2026-10-25T09:10:45.207129+00:00
  4. Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-25T09:10:45.205077+00:00

Methodology

Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.

Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.

Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.

By FN2 Research · Updated · As of 2026-10-25. For educational purposes only; not investment advice.